KJK

(3~{R})-3-[2-[4-(2-azanylethylamino)cyclohexyl]ethanoylamino]-2-oxidanyl-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid



Chemical Component Summary

Name(3~{R})-3-[2-[4-(2-azanylethylamino)cyclohexyl]ethanoylamino]-2-oxidanyl-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid
Identifiers(3~{R})-3-[2-[4-(2-azanylethylamino)cyclohexyl]ethanoylamino]-2-oxidanyl-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid
FormulaC19 H28 B N3 O5
Molecular Weight389.254
TypeNON-POLYMER
Isomeric SMILESB1([C@H](Cc2cccc(c2O1)C(=O)O)NC(=O)CC3CCC(CC3)NCCN)O
InChIInChI=1S/C19H28BN3O5/c21-8-9-22-14-6-4-12(5-7-14)10-17(24)23-16-11-13-2-1-3-15(19(25)26)18(13)28-20(16)27/h1-3,12,14,16,22,27H,4-11,21H2,(H,23,24)(H,25,26)/t12-,14-,16-/m0/s1
InChIKeyPFZUWUXKQPRWAL-NOLJZWGESA-N

Chemical Details

Formal Charge0
Atom Count56
Chiral Atom Count1
Bond Count58
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB16338 
NameTaniborbactam
Groups investigational
DescriptionTaniborbactam is under investigation in clinical trial NCT03840148 (Safety and Efficacy Study of Cefepime/vnrx-5133 in Patients With Complicated Urinary Tract Infections).
SynonymsTaniborbactam
Categories
  • Acids
  • Acids, Noncarboxylic
  • Boron Compounds
CAS number1613267-49-4